GSK-201492

Study Sponsor: GSK

Study Title

A Randomized, Doubled-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of Fluticasone Furoate Nasal Spray 55 mcg and 110 mcg for 4 Weeks in Chinese Pediatric Subjects Ages 2 to 12 Years with Allergic Rhinitis

Medicine or Vaccine (generic name)

fluticasone furoate

Sponsor Identification Number

201492

Trial Registry Identification Number(#'s)

NCT02424539

Medical Condition

Rhinitis, Allergic, Perennial and Seasonal

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=201492

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02424539

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

November 2020